Cited by

• Cannabidiol as a Treatment for Mood Disorders: A Systematic Review.

  Pinto JV, Saraf G, Frysch C, Vigo D, Keramatian K, Chakrabarty T, Lam RW, Kauer-Sant'Anna M, Yatham LN. Pinto JV, et al. Can J Psychiatry. 2020 Apr;65(4):213-227. doi: 10.1177/0706743719895195. Epub 2019 Dec 13. Can J Psychiatry. 2020. PMID: 31830820 Free PMC article.
• Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression.

  Siegel JS, Palanca BJA, Ances BM, Kharasch ED, Schweiger JA, Yingling MD, Snyder AZ, Nicol GE, Lenze EJ, Farber NB. Siegel JS, et al. Psychopharmacology (Berl). 2021 Apr;238(4):1157-1169. doi: 10.1007/s00213-021-05762-6. Epub 2021 Jan 22. Psychopharmacology (Berl). 2021. PMID: 33483802 Free PMC article.
• A Prospective Pilot Trial for Pallidal Deep Brain Stimulation in Huntington's Disease.

  Wojtecki L, Groiss SJ, Ferrea S, Elben S, Hartmann CJ, Dunnett SB, Rosser A, Saft C, Südmeyer M, Ohmann C, Schnitzler A, Vesper J; Surgical Approaches Working Group of the European Huntington's Disease Network (EHDN). Wojtecki L, et al. Front Neurol. 2015 Aug 18;6:177. doi: 10.3389/fneur.2015.00177. eCollection 2015. Front Neurol. 2015. PMID: 26347707 Free PMC article.
• Comparative Effectiveness of Integrated Peer Support and Clinical Staffing Models for Community-Based Residential Mental Health Rehabilitation: A Prospective Observational Study.

  Parker S, Arnautovska U, Korman N, Harris M, Dark F. Parker S, et al. Community Ment Health J. 2023 Apr;59(3):459-470. doi: 10.1007/s10597-022-01023-8. Epub 2022 Sep 3. Community Ment Health J. 2023. PMID: 36057000 Free PMC article.
• No association between polymorphisms of WNT2 and schizophrenia in a Korean population.

  Kim HJ, Park JK, Kim SK, Kang SW, Kim JW, Park HK, Cho AR, Song JY, Chung JH. Kim HJ, et al. BMC Med Genet. 2010 May 24;11:78. doi: 10.1186/1471-2350-11-78. BMC Med Genet. 2010. PMID: 20492734 Free PMC article.